The startup develops a cryopreservation system that utilizes proprietary cold shock inhibitors and membrane protectants to prevent cryoinjury to biological materials. This technology ensures precise control over storage conditions, enabling biotech companies and researchers to preserve biological samples effectively for therapeutic and scientific applications.

DAP combines specialized hardware and analytics software to enhance customer engagement and feedback collection for small, local businesses. This solution addresses the challenge of limited visibility and operational insights, enabling business owners to improve their services based on actionable data.

EBT develops neuromodulation technologies that target the Saphenous nerve to treat pelvic health disorders, beginning with overactive bladder. By leveraging the nerve’s role in pelvic function, the company aims to move neuromodulation from a last‑line option to a primary therapy in patient care pathways.

Giiant Pharma develops gut-restricted, orally delivered small molecule therapeutics specifically targeting inflammatory bowel diseases (IBD) using its Gastrointestinal-Induced Anti-inflammatory technology, which utilizes gut microbiota to activate drugs in the lower GI tract. This approach aims to enhance drug tolerability and minimize systemic side effects, addressing the significant impact of treatment-associated adverse effects on patient quality of life and adherence.

MEDiC utilizes a proprietary CRISPR functional genomics platform combined with 3D tumor models to identify cancer biomarkers and novel drug targets with high precision. This approach addresses the challenge of missed potential biomarkers in current drug development, enhancing the accuracy of patient stratification for oncology treatments.

Provides an API-driven authorization service that enables developers to implement role-based (RBAC), relationship-based (ReBAC), and attribute-based (ABAC) access control without overhauling existing application architectures. By generating SQL filters and authorizing locally against existing databases, it reduces integration time, eliminates syncing issues, and supports high-performance, scalable permission management across cloud, hybrid, and on-prem environments.

ProFound is creating a professional network that connects leaders with disabilities and accessibility advocates to facilitate partnerships and share best practices. The platform enhances disability inclusion and accessibility within organizations by providing access to a diverse talent pool and innovative ideas.

Quest is an audio quality assurance platform that enables experts to share insights and experiences through short audio clips, facilitating knowledge transfer in a concise format. This addresses the challenge of accessing expert advice quickly and efficiently, enhancing learning and decision-making processes for users.

RoMo is an employee recognition app that integrates with Slack and Microsoft Teams, enabling real-time, values-driven recognition among team members. By facilitating quick and meaningful appreciation, RoMo enhances team engagement and performance by 35%, fostering a strong, values-based culture within organizations.

The startup offers an AI-driven platform that connects businesses with suitable partners throughout their innovation journey. By leveraging machine learning algorithms, it enhances strategic collaboration, enabling companies to identify and engage with startups that align with their specific needs.

Veralox Therapeutics is developing small molecule therapeutics that inhibit the 12-Lipoxygenase pathway to treat Heparin-Induced Thrombocytopenia (HIT) and Type 1 Diabetes (T1D). By targeting this enzyme, the company aims to reduce proinflammatory metabolites that contribute to platelet activation in HIT and enhance insulin production in T1D.